2025-08-08 20:12:44
Latest Post
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
RBI grants NBFC license to Equirus Group
Stock Report
RDB Rasayans Ltd Q4 FY2023 net profit drops to Rs. 2.37 crore
Posted On : 2023-05-19 20:37:45( TIMEZONE : IST )
RDB RASAYANS LTD. has reported Standalone financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 30.2810 crores during the period ended March 31, 2023 as compared to Rs. 27.9374 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 2.3756 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 5.7563 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 1.34 for the period ended March 31, 2023 as compared to Rs. 3.25 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹30.2810 crs | ₹27.9374 crs |  8.39% |
| Net Profit | ₹2.3756 crs | ₹5.7563 crs |  -58.73% |
| EPS | ₹1.34 | ₹3.25 | -58.77% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.30.2810 crores during the period ended March 31, 2023 as compared to Rs.35.8678 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.2.3756 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.4.8950 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.1.34 for the period ended March 31, 2023 as compared to Rs.2.76 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹30.2810 crs | ₹35.8678 crs | -15.58% |
| Net Profit | ₹2.3756 crs | ₹4.8950 crs | -51.47% |
| EPS | ₹1.34 | ₹2.76 | -51.45% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.124.1348 crores during the Financial Year ended March 31, 2023 as compared to Rs.135.1755 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.24.3694 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.22.0547 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.13.76 for the Financial Year ended March 31, 2023 as compared to Rs.12.45 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹124.1348 crs | ₹135.1755 crs | -8.17% |
| Net Profit | ₹24.3694 crs | ₹22.0547 crs | 10.50% |
| EPS | ₹13.76 | ₹12.45 | 10.52% |
Shares of RDB RASAYANS LTD. was last trading in BSE at Rs. 89.85 as compared to the previous close of Rs. 89.92. The total number of shares traded during the day was 8977 in over 74 trades.
The stock hit an intraday high of Rs. 91.74 and intraday low of 88.65. The net turnover during the day was Rs. 807812.00.
